OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
(2019)
Open Access | Times Cited: 14
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
(2019)
Open Access | Times Cited: 14
Showing 14 citing articles:
The CCL5/CCR5 Axis in Cancer Progression
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 305
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 305
The Role and Therapeutic Targeting of CCR5 in Breast Cancer
Rasha Hamid, Mustafa Alaziz, Amanpreet S. Mahal, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2237-2237
Open Access | Times Cited: 14
Rasha Hamid, Mustafa Alaziz, Amanpreet S. Mahal, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2237-2237
Open Access | Times Cited: 14
Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
Artem Gusak, Liudmila Fedorova, Kirill V. Lepik, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5676-5676
Open Access | Times Cited: 24
Artem Gusak, Liudmila Fedorova, Kirill V. Lepik, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5676-5676
Open Access | Times Cited: 24
Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy
Maria Raffaella Zocchi, Francesca Tosetti, Roberto Benelli, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1886-1886
Open Access | Times Cited: 24
Maria Raffaella Zocchi, Francesca Tosetti, Roberto Benelli, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1886-1886
Open Access | Times Cited: 24
Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future
Marc Bienz, S. Ramdani, Hans Knecht
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6623-6623
Open Access | Times Cited: 18
Marc Bienz, S. Ramdani, Hans Knecht
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6623-6623
Open Access | Times Cited: 18
The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment
Isacco Ferrarini, Antonella Rigo, Carlo Visco, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3757-3757
Open Access | Times Cited: 17
Isacco Ferrarini, Antonella Rigo, Carlo Visco, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3757-3757
Open Access | Times Cited: 17
Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein–Barr Virus-Specific T-Cells
Sandhya Sharma, Tim Sauer, Bilal Omer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15806-15806
Open Access | Times Cited: 4
Sandhya Sharma, Tim Sauer, Bilal Omer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15806-15806
Open Access | Times Cited: 4
In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869
Naike Casagrande, Cinzia Borghese, Michele Avanzo, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2732-2732
Open Access | Times Cited: 3
Naike Casagrande, Cinzia Borghese, Michele Avanzo, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2732-2732
Open Access | Times Cited: 3
Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis
Yujia Pan, Roza Cengiz, Joost Kluiver, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1126-1126
Open Access
Yujia Pan, Roza Cengiz, Joost Kluiver, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1126-1126
Open Access
The Medium Obtained from the Culture of Hodgkin Lymphoma Cells Affects the Biophysical Characteristics of a Fibroblast Cell Model
Maura Rossi, Francesco Alviano, Barie Myrtaj, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 197-197
Open Access | Times Cited: 1
Maura Rossi, Francesco Alviano, Barie Myrtaj, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 197-197
Open Access | Times Cited: 1
Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview
Wellington Francisco Rodrigues, Camila Botelho Miguel, Melissa Carvalho Martins de Abreu, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5299-5299
Open Access | Times Cited: 1
Wellington Francisco Rodrigues, Camila Botelho Miguel, Melissa Carvalho Martins de Abreu, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5299-5299
Open Access | Times Cited: 1
Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma
Naike Casagrande, Cinzia Borghese, Donatella Aldinucci
Cancers (2022) Vol. 14, Iss. 10, pp. 2427-2427
Open Access | Times Cited: 2
Naike Casagrande, Cinzia Borghese, Donatella Aldinucci
Cancers (2022) Vol. 14, Iss. 10, pp. 2427-2427
Open Access | Times Cited: 2
A Score for Predicting Freedom from Progression of Children and Adolescents with Hodgkin Lymphoma
Vallì De Re, Laura Caggiari, Maurizio Mascarin, et al.
Hemato (2021) Vol. 2, Iss. 2, pp. 264-280
Open Access
Vallì De Re, Laura Caggiari, Maurizio Mascarin, et al.
Hemato (2021) Vol. 2, Iss. 2, pp. 264-280
Open Access
